Form D — Claris Biotherapeutics, Inc.
0001809726-25-000004 · filed 2025-09-22
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,300,000
- Total sold
- $2,300,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Claris Biotherapeutics, Inc.
- CIK
- 1809726
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 299 PAVONIA AVENUE 3-8
JERSEY CITY, NJ 07302 - Phone
- 201-344-7638
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Clarke Atwell · Executive OfficerJersey City, NJ Find on LinkedIn ↗
-
Reza Dana · DirectorJersey City, NJ Find on LinkedIn ↗
-
Kenneth Harrison · DirectorJersey City, NJ Find on LinkedIn ↗
-
Marc de Garidel · DirectorJersey City, NJ Find on LinkedIn ↗
-
Meredith Fisher · DirectorJersey City, NJ Find on LinkedIn ↗
-
Henry Rath · Executive OfficerJersey City, NJ Find on LinkedIn ↗
-
Susan Orr · Executive OfficerJersey City, NJ Find on LinkedIn ↗
View original on SEC EDGAR.